COPD - A New Look at an Old Disease

Activity Details
  • Credit Amounts:
    • CNE: 1.20
    • TSBSWE: 1.00
    • Physicians: 1.00
    • PT: 1.00
  • Cost: Free
  • Release: May 1, 2016
  • Expires: May 1, 2018
  • Estimated Time to Complete:
    1 Hour(s)
  • System Requirements:
  • Average User Rating:
    (8 Ratings)


Nicola Hanania Nicola Hanania, MD, MS, FRCP(C), FCCP, FACP
Associate Professor, Department of Medicine, Section of Pulmonary and Critical Care Medicine,
Director of the Asthma Clinical Research Center,
Baylor College of Medicine in Houston, Texas
Director of the Asthma Adult Clinic and Pulmonary Diagnostic Services, Ben Taub General Hospital, Houston, Texas

Needs Statement

Chronic obstructive pulmonary disease (COPD) is responsible for one death every four minutes in the United States and is now the third leading cause of death. Even though COPD is common and usually progressive and disabling, it is treatable and partially reversible. This presentation will take a look at the epidemiology, pathophysiology, diagnosis, assessment, management, and novel targets for therapy, of COPD.

Target Audience

This activity was planned to meet the educational needs of physicians, nurse practitioners, physician assistants, pharmacists, nurses, physical therapists and social workers.


  • Recognize novel understanding of the pathophysiologic mechanisms of COPD
  • Review current guidelines recommendation for the management of COPD
  • Outline new developments in therapeutic targets of COPD
  • Recognize and implement non-pharmacologic approaches to COPD



UNT Health Science Center is approved by the California Board of Registered Nursing, Provider # 16274. This activity is approved for 1.20 Contact Hours.


This activity is approved for a maximum of 1.00 Clock Hours for Social Workers.


The University of North Texas Health Science Center is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 1.00 hour of AOA Category 2B CME credits. Approval is currently pending.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of North Texas Health Science Center designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

ACGME Competencies

  • Patient care
  • Medical knowledge

IOM Competencies

  • Provide patient-centered care
  • Employ evidence-based practice


UNT Health Science Center is accredited by Texas Physical Therapy Association, Provider 1810035TX. This activity is approved for 1.00 CCU for PTs and PTAs.

For successful completion, a participant must attend the program, complete the evaluation, and request credit online at conclusion of the activity.

The assignment of Texas PT CCUs does not imply endorsement of specific course content, products, or clinical procedures by TPTA or TBPTE.

Faculty Disclosure

Dr. Hanania has disclosed the following affliations with commerical interests:

Research support from:

Roche/Genentech, GSK, Astra Zeneca, Cheisi, Sunovian,

Mylan, Boehringer Ingelheim

Consultant for:

Roche/Genentech, Asta Zeneca, Boehringer Ingelheim,


Speaker Bureau for: Genentech, Sunovion

The UNT Health Science Center Professional and Continuing Education staff and Grand Rounds Planning Committee have nothing to disclose.


Supported by an unrestricted educational grant from Boehringer Ingelheim.

The activity was supported by PACE - General.